Contributions
Abstract: 6
Type: Educational Session
Abstract Category: N/A
In this presentation, we will cover the most important treatment strategies for women and men with MS planning a pregnancy/conception. We will present the most updated safety data on immunomodulatory drugs during pregnancy and if available lactation. The presentation should guide and assist clinicians, to counsel patients with MS planning a pregnancy especially when to stop /restart specific MS treatments in women and men with MS who plan a pregnancy or who became accidentally pregnant under MS drugs.
Disclosure: KH got research support and speaker honoraria from Bayer Healthcare, Biogen Idec, Novartis Pharma, Merck, Sanofi Genzyme, Teva Pharma and Roche.
Abstract: 6
Type: Educational Session
Abstract Category: N/A
In this presentation, we will cover the most important treatment strategies for women and men with MS planning a pregnancy/conception. We will present the most updated safety data on immunomodulatory drugs during pregnancy and if available lactation. The presentation should guide and assist clinicians, to counsel patients with MS planning a pregnancy especially when to stop /restart specific MS treatments in women and men with MS who plan a pregnancy or who became accidentally pregnant under MS drugs.
Disclosure: KH got research support and speaker honoraria from Bayer Healthcare, Biogen Idec, Novartis Pharma, Merck, Sanofi Genzyme, Teva Pharma and Roche.